1. Home
  2. INLX vs AEON Comparison

INLX vs AEON Comparison

Compare INLX & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$6.70

Market Cap

30.4M

Sector

Technology

ML Signal

N/A

Logo AEON Biopharma Inc.

AEON

AEON Biopharma Inc.

HOLD

Current Price

$0.75

Market Cap

25.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
AEON
Founded
1996
N/A
Country
United States
United States
Employees
N/A
8
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.4M
25.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
INLX
AEON
Price
$6.70
$0.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.20
AVG Volume (30 Days)
1.7K
69.1K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,336.00
N/A
Revenue This Year
$16.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$0.53
52 Week High
$14.57
$1.45

Technical Indicators

Market Signals
Indicator
INLX
AEON
Relative Strength Index (RSI) 44.15 32.80
Support Level N/A $0.70
Resistance Level $7.87 $0.83
Average True Range (ATR) 0.28 0.05
MACD -0.04 -0.01
Stochastic Oscillator 29.22 8.14

Price Performance

Historical Comparison
INLX
AEON

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About AEON AEON Biopharma Inc.

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Share on Social Networks: